Top Story

VIDEO: Initial results of ZUMA-3 trial ‘highly encouraging’ for relapsed, refractory leukemia

July 21, 2019

Seven important updates in immuno-oncology

July 19, 2019
Healio.com and HemOnc Today provide a compilation of seven important updates in immuno-oncology from the past month.
Meeting News

ASH announces award recipients

July 15, 2019
Several distinguished leaders in hematology will be honored with awards and special lectures at this year’s ASH Annual Meeting and Exposition, scheduled for Dec…

TAPUR study fulfilling need to better understand targeted therapies, ASCO’s Schilsky says

July 15, 2019
The Targeted Agent and Profiling Utilization Registry , or TAPUR, study is fulfilling a need in clinical research across the United States for patients with advanced…
More Headlines »

Ace the Case: A 54-year-old Man With 2 Weeks of Progressive Shortness of Breath

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 54-year-old man with 2 weeks of…
More »
Meeting News

VIDEO: Servier Pharmaceuticals executive highlights pipeline, ‘focus on the patients’

June 28, 2019
More »
Resource Centers
Discoveries from ASH Leukemia

Discoveries from ASH Leukemia


Focus on Advancing Treatment for Acute Myeloid Leukemia

This activity is supported by an independent educational grant from Pfizer, Inc.

In this activity, Bruno Medieros, MD, and Farhad Ravandi-Kashini, MD, discuss recent advances in the treatment of acute…
More »